JOEM: Hearing Gulf War Chemical Alarms Associated with Cognitive Decline

MINNEAPOLIS STAR-TRIBUNE: Still sick 25 years after the Gulf War, a vet seeks answers — and the Minneapolis VA may have them

Next RAC Gulf War Meeting - Aug. 8-9, 2016, San Francisco

FOX: ‘Must not be forgotten’: Desert Storm vets on mission to build DC memorial

HEALTHLINE/HUFF POST: Gulf War Veterans Still Fighting Serious Health Problems

MILITARY TIMES: Research provides clues to effective treatments for Gulf War illness

VA Gulf War Research Advisory Committee to Meet in Public Teleconference on June 25

ACTION ALERT: Call Now for Gulf War Research Not Red Tape

UPDATE:  The amendment passed, narrowly, by a vote of 66-32.  These medical research programs have survived another attempt to destroy them.  

The roll call vote is posted below.

3 New Drugs for Fibromyalgia on the Way?

(91outcomes.com) - A new article discussed in detail three new drugs that could be on the way for fibromyalgia.  Fibromyalgia, a condition with chronic widespread pain at its core, is a presumptive for Veterans Affairs disability claims for veterans with Persian Gulf service from 1990 to the present.

The new drugs that could prove beneficial for fibromyalgia sufferers include:

• IMC-1, "a combination of famciclovir (Famvir), a common antiviral, with celecoxib (Celebrex), an anti-inflammatory arthritis drug," for an FDA-cleared Phase III clinical trial in 2017.

• Microgabalin (DS-5565), "which relieves pain by binding to the body’s calcium channels," but, with, "a unique binding profile and long duration of action at voltage gated calcium channels."

• Tonmya (TNX-102 SL), a new under-the-tongue formulation of cyclobenzaprine HCL 2.8 mg to improve sleep quality, and, it is hoped thereby, other fibromyalgia symptoms.

Read the full, very well written article by Donna Gregory Burch for the National Pain Report, at:  http://nationalpainreport.com/three-new-fibromyalgia-drugs-could-be-on-the-way-8830514.html

VA Public Teleconference on Report Recommending Ending Certain Gulf War Research

New Study Finds Brain Function Differences in Gulf War Illness National Sample

New Study Shows Epigenetic Changes in Gulf War Toxin Rat Model

The study on which these findings are based was funded by the treatment-focused Gulf War Illness Research Program (GWIRP), within the Congressionally Directed Medical Research Program (CDMRP) administered by the U.S. Department of Defense health program.

Most notably, according to the study's findings, "Results from this study implicate a role for epigenetic alterations in GWI."

NEWSMAX: CoQ10 Helps Gulf War Syndrome

Editor's Note:  The article is reporting on a treatment study by Dr. Beatrice Golomb of the University of California-San Diego that was funded by the Gulf War Illness Research Program (GWIRP) within the Congressionally Directed Medical Research Program (CDMRP) administered by the U.S. Department of Defense Health Programs under Congressional direction.

The CoQ10 utilized in the study is pharmaceutical grade, and not the variety sold at Walmart, Costco, etc.   The ubiquinone version of CoQ10 was used in the study.

Roskamp Researcher Awarded CDMRP Grant for Inflammatory, Metabolic Biomarkers

This study is funded by the Gulf War Illness Research Program (GWIRP) within the Congressionally Directed Medical Research Programs (CDMRP), which are carried out under specific Congressional direction by the Department of Defense.

VA Hosting Gulf War Veteran Roundtable, Researchers, Town Hall Meeting this Week

(91outcomes.com) – The U.S. Department of Veterans (VA) Affairs Research Advisory Committee on Gulf War Veterans Illnesses (RAC-GWVI) will hold its next meetings on Thursday and Friday, April 28-29, 2016 in Washington, DC.

US MEDICINE: Advocates Describe Difficulties in Getting Gulf War Illness Diagnosis

SOURCE:  U.S. Medicine, April 2016, written by Sandra Basu
http://www.usmedicine.com/agencies/department-of-veterans-affairs/advocates-describe-difficulties-in-getting-gulf-war-illness-diagnosis/

ARCHIVED ARTICLE:

Advocates Describe Difficulties in Getting Gulf War Illness Diagnosis 

April 2016 | Department of Veterans Affairs (VA) | News 

Legislators Agree That Research on Causes Needs to Continue

By Sandra Basu

WASHINGTON — Veterans are experiencing a high number of denials of Gulf War Illness-related claims at least partly because the condition “presents itself in a way that is not conducive to the traditional VA disability claims process,” an advocacy group told lawmakers last month.

“Gulf War Illness is an inherently difficult condition to diagnose and treat,” said Aleks Morosky, legislative service deputy director for the Veterans of Foreign Wars of the United States (VFW). “This is because it presents itself as a host of possible symptoms common to many veterans, rather than a single condition that is clearly identifiable and unmistakable.”

FIBROMYALGIA NEWS TODAY: Pain Sensitivity in Mice with Fibromyalgia Reduced with Natural Compounds

Editor's Note:  Fibromyalgia is a presumptive condition for VA claims purposes for Gulf War veterans.  The medical and pathophysiological relationships between fibromyalgia and the chronic widespread pain common in many Gulf War Illness patients remains unclear.

FREDERICKSBURG.COM: Gulf War veteran is fighting again--Battling Multiple Sclerosis

FOR RESEARCHERS: Request for Proposals Pre-Announcement - Gulf War Illness Treatment Research Funding Availability

New England/Mass. Gulf War Veterans Needed for Gulf War Illness Study

The following multi-site study is funded by the Gulf War Illness Research Program (GWIRP), within the Congressionally Directed Medical Research Program (CDMRP) administered by the U.S. Department of Defense Health Programs under Congressional direction.  

Other sites recruiting include Miami, Florida and Houston, Texas.  More information about the Gulf War Illness Consortium (GWIC) is available from the GWIC website.

-91outcomes


***